Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1666916Generated: November 1, 2026

Hydrogen Peroxide → HCID 67443709, compound

https://huagongshe.com/reaction/1666916

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrogen PeroxideHCID 784—
ReactantSodium SulfiteHCID 24437—
ReactantSodium ChloriteHCID 23668197—
ReactantMonosodium phosphateHCID 23672064—
ReactantHCID 86639156HCID 86639156—
SolventWaterHCID 962—
SolventAcetonitrileHCID 6342—
ProductHCID 67443709HCID 6744370991.6%

Reaction Steps

To a mixture of methyl (S)-{4-(4-chlorophenyl)-2-formyl-3,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl}acetate (429 mg) synthesized in Example 342 as an intermediate, palladium acetate (11 mg), 2-(di-tert-butylphosphino)biphenyl (30 mg), potassium fluoride (349 mg) and 3-cyanophenylboronic acid (441 mg) was added tetrahydrofuran (4 mL), and the mixture was heated under reflux for 6 hr. After cooling, water was added, and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and the solvent was evaporated. The residue was purified by column chromatography (chloroform:methanol=100:1) to give methyl (S)-{4-(3′-cyanobiphenyl-4-yl)-2-formyl-3,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl}acetate (588 mg). The obtained methyl (S)-{4-(3′-cyanobiphenyl-4-yl)-2-formyl-3,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl}acetate (564 mg) was dissolved in acetonitrile (4 mL), and aqueous sodium dihydrogen phosphate solution (128 mg/1.6 mL) was added. To the reaction mixture were successively added 35% hydrogen peroxide solution (0.5 mL) and aqueous sodium chlorite solution (174 mg/0.6 mL) at 0° C., and the mixture was stirred for 1 hr on a water bath. After completion of the reaction, water was added, and the mixture was worked up with sodium sulfite. The aqueous layer was acidified and extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and the solvent was evaporated to give (S)-4-(3′-cyanobiphenyl-4-yl)-6-methoxycarbonylmethyl-3,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-carboxylic acid (500 mg). The obtained (S)-4-(3′-cyanobiphenyl-4-yl)-6-methoxycarbonylmethyl-3,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-carboxylic acid (487 mg) and copper (50 mg) were reacted at 150° C. for 30 min in quinoline. After completion of the reaction, water was added, and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and the solvent was evaporated. The residue was purified by column chromatography (chloroform:methanol=100:1) and recrystallized from ethyl acetate to give the title compound (217 mg).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08044042B2
Source datasetuspto-grants-2011_10
ORD IDord-9b6c7fc53a554f848015e345a647ac0b
Source noteuspto-grants-2011_10